Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed As Successor; Reiterates Previously Issued Financial Guidance
Dec 21, 2023•almost 2 years ago
Company
Myriad Genetics
Description
Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced the appointment of Scott Leffler as Chief Financial Officer , effective January 29, 2024. Leffler will succeed Myriad CFO Bryan Riggsbee who is retiring. Riggsbee will continue as a strategic advisor through March 31, 2024, to ensure a smooth transition.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months